RECRUITING

Comparing Two Ways to Manage Head and Neck Lymphedema

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.

Official Title

Comparing Two Ways to Manage Lymphedema in Head and Neck Cancer Survivors

Quick Facts

Study Start:2022-03-11
Study Completion:2026-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05182229

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * \>18 years of age
  2. * \<=24 months post-HNC treatment
  3. * Diagnosis of head and neck lymphedema and referral by their oncology providers
  4. * Able to perform self-manual lymphatic drainage
  5. * Having an electronic device (a computer, tablet, iPad, laptop, or smartphone) and internet access at home
  1. * Active infection in soft tissues in the head and neck region
  2. * History of moderate or severe carotid artery occlusion
  3. * Significantly severe lymphedema (e.g., severe periorbital swelling)
  4. * Conditions impacting the safe delivery of lymphedema therapy

Contacts and Locations

Study Contact

Jie Deng, PhD
CONTACT
215-573-2393
jiedeng@nursing.upenn.edu

Study Locations (Sites)

University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107
United States
Temple University Hospital and Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19140
United States

Collaborators and Investigators

Sponsor: Abramson Cancer Center at Penn Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-11
Study Completion Date2026-11-30

Study Record Updates

Study Start Date2022-03-11
Study Completion Date2026-11-30

Terms related to this study

Additional Relevant MeSH Terms

  • Head and Neck Cancer
  • Lymphedema